Drugs / Inflexal V
last change Dec 2013 re-read 2 minutes ago

Inflexal V

Vaccine

Developed for
influenza
Investigated by
Crucell Holland BV

Trials 11 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01617239 Jun 2012 → Jun 2013 influenza Crucell Holland BV Completed No outcome recorded
Phase 35 trials
Phase 3 NCT01893177 Jul → Aug 2013 influenza Crucell Holland BV Completed No outcome recorded
Phase 3 NCT01631110 Jul → Aug 2012 influenza Crucell Holland BV Completed No outcome recorded
Phase 3 NCT01229397 Oct → Nov 2010 influenza Crucell Holland BV Completed No outcome recorded
Phase 3 NCT01229371 Oct → Dec 2010 influenza Crucell Holland BV Completed No outcome recorded
Phase 3 NCT01310400 Oct 2009 → Jan 2010 influenza Crucell Holland BV Completed No outcome recorded
Phase 44 trials
Phase 4 NCT01457027 Oct 2011 → Aug 2012 influenza Crucell Holland BV Completed No outcome recorded
Phase 4 NCT01306305 Jun → Jul 2010 influenza Crucell Holland BV Completed No outcome recorded
Phase 4 NCT01306253 Jun 2009 influenza Crucell Holland BV Completed No outcome recorded
Phase 4 NCT01303510 Jul 2008 influenza Crucell Holland BV Completed No outcome recorded
Phase not applicable1 trial
NCT01631071 Jul → Aug 2012 influenza Crucell Holland BV Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00513669 Comparator Jan 2008 → Mar 2009 Plasmodium falciparum malaria Swiss Tropical & Public Health Institute Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01412281 Comparator Oct → Dec 2011 influenza Crucell Holland BV Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 14 sources stand behind the page.

FieldValueCited text
Known as InflexalV “The purpose of this study is to assess the humoral immune response and safety of the parenteral formulation of the 2010/2011-season virosomal subunit influenza vaccine Inflexal...” NCT01412281
11

“virosomal influenza vaccine Inflexal®V on day 0 and 90” PMID 21799810 Jul 2011

NCT01310400

NCT01306305

NCT01893177

NCT00513669

NCT01229371

NCT01306253

NCT01631110

NCT01457027

NCT01229397

NCT01303510

Known as Inflexal V influenza vaccine Inflexal V influenza vaccine (surface antigen, inactivated, virosome, using CSL HA Antigen) 2010/2011, with intramuscular administration” NCT01229371
Known as Virosomal Influenza Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01631071
1

NCT01617239

Modality Vaccine “virosomal influenza vaccine Inflexal®V on day 0 and 90” PMID 21799810 Jul 2011
Route Intramuscular “with intramuscular administration” NCT01229371